HA
DMK

Harbor Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Harbor Advisors’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-143
Closed -$9K – 197
2021
Q1 		$9K Buy
+143
New +$11.1K ﹤0.01% 199

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

Harbor Advisors's DMK Position: Q2 2021 in Review

Harbor Advisors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q2 2021, closing a stake of 143 shares — an estimated $9K sold.

Harbor Advisors first reported a position in DMK in Q1 2021 and held it in 1 quarter. The position peaked at $9K in Q1 2021. 51 funds tracked by Wall St. Rank hold DMK as of Q2 2021.

  • Harbor Advisors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q2 2021 after selling out during the quarter.
  • Harbor Advisors sold 143 DMK Pharmaceuticals Corporation Common Stock shares in Q2 2021, an estimated $9K.
  • Harbor Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2021 and held it in 1 quarter.
  • Harbor Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $9K in Q1 2021.
  • 51 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q2 2021.

Based on Harbor Advisors's 13F filing for Q2 2021, filed 3 Aug 2021.